IQV · IQVIA Holdings Inc.

S&P 500 #120 · NYSE

Risiko 5/10 · moderate · $242.94 ▲ 13.94%

Kennzahlen

• Price $242.94
• Market cap $40.5B
• P/E (ttm) 30.14
• Div yield none
• 52-wk range $154.50 – $247.72
• Index rank #120 / —

Wichtigste Risiken

• Biopharma R&D budget cuts (pharma clients) — HIGH
• Clinical-trial bookings (R&D backlog) — MED
• Funding-environment for biotech (emerging clients) — MED
• FX exposure (global ops) — LOW

Fazit

Clinical-research and healthcare-data CRO whose growth tracks biopharma R&D spending and trial bookings.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.